Researchers found that miR-125b levels were significantly higher in patients with atherosclerosis compared to controls, suggesting it could be a potential therapeutic target. STAT3 exhibited high diagnostic power, underscoring its potential as a biomarker. The study also observed significant correlations between miR-125b and biochemical parameters.
